STOCK TITAN

Exponent (NASDAQ: EXPO) vice president sells 2,000 shares in open trade

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Exponent Inc. Group Vice President James Bradley reported an open-market sale of 2,000 shares of Common Stock on May 26, 2026 at an average price of $57.465 per share. Following this transaction, he directly holds 1,105 shares of Exponent common stock.

Positive

  • None.

Negative

  • None.
Insider James Bradley A
Role Group Vice President
Sold 2,000 shs ($115K)
Type Security Shares Price Value
Sale Common Stock 2,000 $57.465 $115K
Holdings After Transaction: Common Stock — 1,105 shares (Direct, null)
Footnotes (1)
Shares sold 2,000 shares Open-market sale of Exponent Common Stock
Sale price per share $57.465 per share Average price for the 2,000 shares sold
Shares held after transaction 1,105 shares Direct holdings of James Bradley following the sale
Transaction code S Indicates sale in open market or private transaction
open-market sale financial
"reported an open-market sale of 2,000 shares of Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"2,000 shares of Common Stock on May 26, 2026"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"according to a new Form 4 filing"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
James Bradley A

(Last)(First)(Middle)
149 COMMONWEALTH DRIVE

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Group Vice President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/26/2026S2,000D$57.4651,105D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
By: Wendy Whitehouse For: Bradley A. James05/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Exponent (EXPO) report for James Bradley?

Exponent reported that Group Vice President James Bradley sold 2,000 shares of Common Stock in an open-market transaction. The sale occurred at an average price of $57.465 per share, and it was disclosed on a Form 4 insider filing.

How many Exponent (EXPO) shares did James Bradley retain after the sale?

After selling 2,000 shares, James Bradley directly holds 1,105 shares of Exponent common stock. This post-transaction balance reflects his remaining direct ownership as reported in the Form 4 insider filing data.

At what price were James Bradley’s Exponent (EXPO) shares sold?

James Bradley’s 2,000 Exponent shares were sold at an average price of $57.465 per share. This price reflects the per-share consideration disclosed for the open-market sale transaction in the insider filing data.

What type of transaction did Exponent (EXPO) disclose for James Bradley?

The transaction was classified as a non-derivative open-market sale of Exponent Common Stock. It carried transaction code “S,” indicating a sale in the open market or a private transaction under SEC Form 4 reporting rules.

Does the Exponent (EXPO) Form 4 show any derivative securities for James Bradley?

The Form 4 data for James Bradley shows no derivative securities transactions or remaining derivative positions. The derivativeSummary is empty, indicating only a common stock sale was reported in this particular filing.